Skip to content
NewsBlazeAU – Lifestyle
Author:
XORTX Therapeutics Inc.
XORTX Appoints New Director
July 29, 2026
XORTX Provides Corporate Update and Announces Appointment of Mika Grasso as Co-CEO
June 15, 2026
XORTX Announces Election to Voluntary Delist from the TSX Venture Exchange
June 12, 2026
XORTX Announces Closing of US$5 Million Public Offering
May 19, 2026
XORTX Announces US$5 Million Public Offering
May 14, 2026
XORTX Meets Nasdaq Continued Listing Requirements
April 21, 2026
XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset
April 14, 2026
XORTX Confirms Effective Date of Share Consolidation
April 2, 2026
XORTX Announces Results of Annual and Special Meeting of Shareholders
March 28, 2026
XORTX Announces Results of Annual and Special Meeting of Shareholders
March 27, 2026
1
2
Next Page
→